Why these two get studied together The short answer is that the preclinical literature on each peptide individually points at overlapping but distinct elements of the wound-repair toolkit: BPC-157 has been associated with angiogenesis and growth-factor signaling, while thymosin beta-4 fragments have been associated with cell migration
minimal systemic safety data available Learn More Which Peptide for Which Application
In two Phase 2 clinical trials covering stasis and pressure ulcers, TB4 accelerated complete wound closure by almost a month in patients who achieved full healing representing one of the most substantial healing acceleration outcomes observed for a peptide compound in a controlled clinical investigation
It works by stimulating angiogenesis, the formation of new blood vessels, which improves blood supply to damaged tissues
What It Does Effectively supports blood sugar balance by improving glucose metabolism and utilization
Final Thoughts: Where to Inject Peptides Understanding where to inject peptides can make peptide therapy feel less intimidating and help support a more comfortable treatment experience
